129 related articles for article (PubMed ID: 29109759)
1. Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis.
Li Y; Cai X; Chen B; Gu H; Liu C
Exp Ther Med; 2017 Nov; 14(5):4862-4868. PubMed ID: 29109759
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer.
Luo Y; Qin SL; Mu YF; Wang ZS; Zhong M; Bian ZQ
Biomed Pharmacother; 2015 Jul; 73():135-9. PubMed ID: 26211594
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer.
Guo Z; Chen X; Du T; Zhu D; Lai Y; Dong W; Wu W; Lin C; Liu L; Huang H
Med Oncol; 2017 Jan; 34(1):13. PubMed ID: 28012134
[TBL] [Abstract][Full Text] [Related]
4. Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA.
Bai X; Yi M; Xia X; Yu S; Zheng X; Wu K
Cancer Manag Res; 2018; 10():4039-4050. PubMed ID: 30319288
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer.
Xiu Y; Liu W; Wang T; Liu Y; Ha M
Mol Clin Oncol; 2019 May; 10(5):497-505. PubMed ID: 30967944
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic expression of epithelial cell transforming sequence 2 in lung adenocarcinoma and its implications for malignant progression.
Kosibaty Z; Murata Y; Minami Y; Dai T; Kano J; Matsuoka R; Nakano N; Noguchi M
Lab Invest; 2019 Apr; 99(4):551-567. PubMed ID: 30542068
[TBL] [Abstract][Full Text] [Related]
7. Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma.
Zhu L; Qin G; Ye L; Jiang LZ; Zhou TJ; Luo B; Wen TY; Liu YL; Chen HY
Oncol Lett; 2019 Jun; 17(6):5699-5704. PubMed ID: 31186795
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma.
Wang Y; Wei J; Zhang S; Li G; Zhang T; Yu X; Chen H; Liu M
Tumour Biol; 2015 Nov; 36(11):8781-7. PubMed ID: 26055144
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of ECT2 in invasive breast cancer.
Wang HK; Liang JF; Zheng HX; Xiao H
J Clin Pathol; 2018 May; 71(5):442-445. PubMed ID: 29051317
[TBL] [Abstract][Full Text] [Related]
10. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
11. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of ECT2 predicts the poor prognosis of breast cancer patients.
Yi M; Zhang D; Song B; Zhao B; Niu M; Wu Y; Dai Z; Wu K
Exp Hematol Oncol; 2022 Dec; 11(1):107. PubMed ID: 36572949
[TBL] [Abstract][Full Text] [Related]
15. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.
Du Y; Liu L; Wang C; Kuang B; Yan S; Zhou A; Wen C; Chen J; Wu Y; Yang X; Feng G; Liu B; Iwamoto A; Zeng M; Wang J; Zhang X; Liu H
Oncotarget; 2016 Jul; 7(27):41885-41897. PubMed ID: 27248823
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA-induced inhibition of epithelial cell transforming sequence 2 suppresses the proliferation, migration and invasion of osteosarcoma cells.
Xie J; Lei P; Hu Y
Exp Ther Med; 2015 May; 9(5):1881-1886. PubMed ID: 26136909
[TBL] [Abstract][Full Text] [Related]
17. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
He H; Wu G; Li W; Cao Y; Liu Y
Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
[TBL] [Abstract][Full Text] [Related]
18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
19. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
20. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
